Rchr
J-GLOBAL ID：200901027407686555   Update date: Jul. 17, 2024

Nirei Kazushige

ニレイ カズシゲ | Nirei Kazushige
Affiliation and department：
Nihon University School of Medicine, Department of Medicine

About Nihon University School of Medicine, Department of Medicine


Research field  (1)： Internal medicine - General
Research theme for competitive and other funds  (1)：
  • 2017 - 2020 Sorafenib resistance and c-Jun in hepatocellular carcinoma
Papers (55)：
  • Masaaki Korenaga, Kazumoto Murata, Namiki Izumi, Nobuharu Tamaki, Osamu Yokosuka, Tetsuo Takehara, Naoya Sakamoto, Goki Suda, Shuhei Nishiguchi, Hirayuki Enomoto, et al. No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy. Global health & medicine. 2022. 4. 4. 216-224
  • Ryota Masuzaki, Tatsuo Kanda, Reina Sasaki, Naoki Matsumoto, Kazushige Nirei, Masahiro Ogawa, Seth J Karp, Mitsuhiko Moriyama, Hirofumi Kogure. Suppressors of Cytokine Signaling and Hepatocellular Carcinoma. Cancers. 2022. 14. 10
  • Tomotaka Ishii, Keijiro Hoshino, Masayuki Honda, Yoichiro Yamana, Reina Sasaki-Tanaka, Mariko Kumagawa, Shini Kanezawa, Taku Mizutani, Naoki Matsumoto, Ryota Masuzaki, et al. A Case of Recent Liver Injury Induced by Benzbromarone. Reports. 2022. 5. 1. 8
  • Taku Mizutani, Kazushige Nirei, Tatsuo Kanda, Masayuki Honda, Tomotaka Ishii, Shuhei Arima, Yoichiro Yamana, Naoki Matsumoto, Shunichi Matsuoka, Mitsuhiko Moriyama. Left Gastric Vein Width Is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients. Medicina (Kaunas, Lithuania). 2022. 58. 2
  • Chikako Ikegami, Tatsuo Kanda, Tomotaka Ishii, Masayuki Honda, Yoichiro Yamana, Reina Sasaki Tanaka, Mariko Kumagawa, Shini Kanezawa, Taku Mizutani, Hiroaki Yamagami, et al. COVID-19 After Treatment With Direct-acting Antivirals for HCV Infection and Decompensated Cirrhosis: A Case Report. In vivo (Athens, Greece). 2022. 36. 4. 1986-1993
ｍore...
MISC (3)：
  • Kaneko T, Kanda T, Nirei K, Matsumoto N, Yamazaki M, Shibata T, Tamura A, Ogawa M, Nakajima N, Matsuoka S, et al. Follow-up Results of HCV GT2 Patients after Sofosbuvir/Ribavirin Therapy: Careful Attention to Occurrence of HCC. Anticancer Res. 2019. 39. 7. 3855-3862
  • Nirei Kazushige. Direct-Acting Antiviral (DAA) Therapy for Chronic Hepatitis C. Journal of Nihon University Medical Association. 2016. 75. 6. 251-253
  • KOINUMA masayoshi, Shinichiro Suzuki, Tsuyoshi Hoshino, Takashi Kawaguchi, Yuki Sasaki, Susumu Otsuka, Yoshikazu Yoshida, Kazushige Nirei, Mitsuhiko Moriyama, Hitoshi Nakamura. Prediction of the Lowest Level of Thrombocytopenia to Avoid Thrombocytopenia-related Treament Discontinuation in PEG-IFNα-2b/RBV Combination Therapy. Japanese Society of Pharmaceutical Health Care and Sciences. 2012. 38. 1. 43-50
Lectures and oral presentations  (7)：
  • SVRを目指したDAA製剤の選択 当院におけるC型慢性肝炎に対するDirect-Acting Antiviral(DAA)療法
    (2016)
  • C型肝炎治療の進歩 慢性C型肝炎・肝硬変に対するインターフェロン治療は発癌を抑止し得たのか 長期予後の観察とSVRに発生した肝癌症例の検討より(会議録)Author:楡井 和重(日本大学 医学部内科学系消化器肝臓内科学分野), 松村 寛, 森山 光彦Source: 肝臓 (0451-4203)55巻Suppl.3 PageA707(2014.10)所蔵確認 SFX
    (2014)
  • 肝癌治療のアルゴリズムとその成績 肝癌の予後について
    (日本消化器病学会雑誌(0446-6586)103巻臨増総会 2006)
  • B型慢性肝炎に対するインターフェロン治療の長期予後
    (日本消化器病学会 2006)
  • 輸血後E型肝炎の1症例
    (関根直樹森山光彦, 田村彰教, 松岡千花子, 小松直人, 楡井和重, 青木宏, 清水敏弘, 金子弥樹, 塩田淳朗, 栗原竜一, 朝岡昭, 田中直英, 荒川泰行, 山崎哲男, 清水一史 2006)
ｍore...
Work history (1)：
  • Nihon University School of Medicine, Department of Medicine Associate Professor
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM